Proteasome inhibition induces cytokeratin accumulation in vivo

Experimental and Molecular Pathology

Volumn 76, Issue 2, 2004, Pages 83-89

  Bardag Gorce, Fawzia ^a   Vu, Jennifer ^a   Nan, Li ^a   Riley, Nora ^a   Li, Jun ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver; ChT L; Chymotrypsin like activity; Cytokeratin aggregation; Heat shock protein; Hsp; Proteasome inhibition

Indexed keywords

ALCOHOL; BORTEZOMIB; CYTOKERATIN 18; CYTOKERATIN 8; GLUCOSE; HEAT SHOCK PROTEIN 25; HEAT SHOCK PROTEIN 70; POLYUBIQUITIN; PROTEASOME; PROTEASOME INHIBITOR; RED FLUORESCENT PROTEIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE INTAKE; LIVER CELL; LIVER HOMOGENATE; MALE; MALLORY BODY; MOUSE; NONHUMAN; RAT; TISSUE CULTURE;

ALCOHOLISM; ANIMALS; BLOTTING, WESTERN; BORONIC ACIDS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; HEAT-SHOCK PROTEINS; HEPATOCYTES; KERATINS; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MULTIENZYME COMPLEXES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RATS;

EID: 1542328879     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.11.004     Document Type: Article

References (23)

1. Bardag-Gorce F., Yuan Q.X., Li J., French B.A., Fang C., Ingelman-Sundberg M., French S.W. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. 279(1):2000;23-29.
2. Bardag-Gorce F., Li J., French B.A., French S.W. Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341. Free Radical Biol. Med. 32(1):2002;17-21.
3. Bardag-Gorce F., Riley N.E., Nan L., Montgomery R.O., Li J., French B.A., Lue Y., French S.W. The proteasome inhibitor, PS-341, causes cytokeratin-aggresome formation. Exp. Mol. Pathol. 2004;. (in press).
4. Blouin R., Kawahara H., French S.W., Marceau N. Selective accumulation of IF proteins at a focal juxtanuclear site in COS-1 cells transfected with mouse keratin 18 cDNA. Exp. Cell Res. 187:1990;234-242.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Ding Q., Keller J.N. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77(4):2001;1010-1017.
7. Donohue T.M. Jr., Zetterman R.K., Zhang-Gouillon Z.Q., French S.W. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Hepatology. 28(2):1998;486-491.
8. Fataccioli V., Andraud E., Gentil M., French S.W., Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology. 29(1):1999;14-20.
9. French S.W., Mayer R.J., Bardag-Gorce F., Ingelman-Sundberg M., Rouach H., Neve A.E., Higashitsuji H. The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugs. Alcohol., Clin. Exp. Res. 25(5 Suppl. ISBRA):2001;225S-229S.
10. Gouillon Z.Q., Miyamoto K., Donohue T.M. Jr., Wan Y.J., French B.A., Nagao Y., Fu P., Reitz R.C., Hagbjork A., Yap C., Yuan Q.X., Ingelman-Sundberg M., French S.W. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway. Front. Biosci. 4:1999;A16-A25.
11. Harada M., Kumemura H., Omary M.B., Kawaguchi T., Maeyama N., Hanada S., Taniguchi E., Koga H., Suganuma T., Ueno T., Sata M. Proteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatus. Exp. Cell Res. 288(1):2003;60-69.
12. Hirano K., Roth J., Zuber C., Ziak M. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation. Histochem. Cell Biol. 117:2002;41-53.
13. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143(7):1998;1883-1898.
14. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75(1):2000;436-439.
15. Ku N.O., Omary M.B. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J. Cell Biol. 149(3):2000;547-552.
16. Lopez Salon M., Morelli L., Castano E.M., Soto E.F., Pasquini J.M. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62(2):2000;302-310.
17. Mayer R.J., Lowe J., Landon M., McDermott H., Tuckwell J., Doherty F., Laszlo L. Ubiquitin and the lysosome system: molecular immunopathology reveals the connection. Biomed. Biochim. Acta. 50(4-6):1991;333-341.
18. McNaught K.S., Mytilineou C., Jnobaptiste R., Yabut J., Shashidharan P., Jennert P., Olanow C.W. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J. Neurochem. 81(2):2002;301-306.
19. Parcellier A., Schmitt E., Gurbuxani S., Seigneurin-Berny D., Pance A., Chantome A., Plenchette S., Khochbin S., Solary E., Garrido C. HSP 27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol. Cell. Biol. 23(16):2003;5790-5802. (Aug).
20. Perez M.J., Cederbaum A.I. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells. Hepatology. 37(6):2003;1395-1404.
21. Riley N.E., Li J., McPhaul L.W., Bardag-Gorce F., Lue Y.H., French S.W. Heat shock proteins are present in Mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp. Mol. Pathol. 74(2):2003;168-172.
22. Stangl K., Gunther C., Frank T., Lorenz M., Meiners S., Ropke T., Stelter L., Moobed M., Baumann G., Kloetzel P.M., Stangl V. Inhibition of the ubiquitin-proteasome pathway induces differential heat shock protein response in cardiomyocytes and renders early cardiac protection. Biochem. Biophys. Res. Commun. 291(3):2002;542-549.
23. Yuan Q.X., Nagao Y., French B.A., Wan Y.J., French S.W. Dexamethasone enhances Mallory body formation in drug-primed mouse liver. Exp. Mol. Pathol. 69(3):2000;202-210.